136 related articles for article (PubMed ID: 27569540)
1. Measurement of urine indolylacroylglycine is not useful in the diagnosis or dietary management of autism.
Dalton NR; Chandler S; Turner C; Charman T; Pickles A; Simonoff E; Baird G
Autism Res; 2017 Mar; 10(3):408-413. PubMed ID: 27569540
[TBL] [Abstract][Full Text] [Related]
2. Can urinary indolylacroylglycine levels be used to determine whether children with autism will benefit from dietary intervention?
Wilson J; Wright B; Jost S; Smith R; Pearce H; Richardson S
Pediatr Res; 2017 Apr; 81(4):672-679. PubMed ID: 27879968
[TBL] [Abstract][Full Text] [Related]
3. Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms?
Wang L; Angley MT; Gerber JP; Young RL; Abarno DV; McKinnon RA; Sorich MJ
Biomarkers; 2009 Dec; 14(8):596-603. PubMed ID: 19697973
[TBL] [Abstract][Full Text] [Related]
4. Is the presence of urinary indolyl-3-acryloylglycine associated with autism spectrum disorder?
Wright B; Brzozowski AM; Calvert E; Farnworth H; Goodall DM; Holbrook I; Imrie G; Jordan J; Kelly A; Miles J; Smith R; Town J
Dev Med Child Neurol; 2005 Mar; 47(3):190-2. PubMed ID: 15739724
[TBL] [Abstract][Full Text] [Related]
5. Indolyl-3-acryloylglycine (IAG) is a putative diagnostic urinary marker for autism spectrum disorders.
Bull G; Shattock P; Whiteley P; Anderson R; Groundwater PW; Lough JW; Lees G
Med Sci Monit; 2003 Oct; 9(10):CR422-5. PubMed ID: 14523330
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of gluten free diet use among preschool children with autism spectrum disorder.
Rubenstein E; Schieve L; Bradley C; DiGuiseppi C; Moody E; Thomas K; Daniels J
Autism Res; 2018 Jan; 11(1):185-193. PubMed ID: 29155492
[TBL] [Abstract][Full Text] [Related]
7. Developmental-behavioral profiles in children with autism spectrum disorder and co-occurring gastrointestinal symptoms.
Restrepo B; Angkustsiri K; Taylor SL; Rogers SJ; Cabral J; Heath B; Hechtman A; Solomon M; Ashwood P; Amaral DG; Nordahl CW
Autism Res; 2020 Oct; 13(10):1778-1789. PubMed ID: 32767543
[TBL] [Abstract][Full Text] [Related]
8. Gut permeability in autism spectrum disorders.
Dalton N; Chandler S; Turner C; Charman T; Pickles A; Loucas T; Simonoff E; Sullivan P; Baird G
Autism Res; 2014 Jun; 7(3):305-13. PubMed ID: 24339339
[TBL] [Abstract][Full Text] [Related]
9. Aggressive behaviors and treatable risk factors of preschool children with autism spectrum disorder.
Chen C; Shen YD; Xun GL; Cai WX; Shi LJ; Xiao L; Wu RR; Zhao JP; Ou JJ
Autism Res; 2017 Jun; 10(6):1155-1162. PubMed ID: 28266803
[TBL] [Abstract][Full Text] [Related]
10. Clustering of co-occurring conditions in autism spectrum disorder during early childhood: A retrospective analysis of medical claims data.
Vargason T; Frye RE; McGuinness DL; Hahn J
Autism Res; 2019 Aug; 12(8):1272-1285. PubMed ID: 31149786
[TBL] [Abstract][Full Text] [Related]
11. Incontinence in children with autism spectrum disorder.
von Gontard A; Pirrung M; Niemczyk J; Equit M
J Pediatr Urol; 2015 Oct; 11(5):264.e1-7. PubMed ID: 26052001
[TBL] [Abstract][Full Text] [Related]
12. [Association between behavioral problems and gastrointestinal disorders among children with autism spectrum disorder].
Zhu J; Guo M; Yang T; Lai X; Lei YY; He ML; Chen J; Li TY
Zhonghua Er Ke Za Zhi; 2017 Dec; 55(12):905-910. PubMed ID: 29262469
[No Abstract] [Full Text] [Related]
13. Altered tactile processing in children with autism spectrum disorder.
Tavassoli T; Bellesheim K; Tommerdahl M; Holden JM; Kolevzon A; Buxbaum JD
Autism Res; 2016 Jun; 9(6):616-20. PubMed ID: 26568449
[TBL] [Abstract][Full Text] [Related]
14. Sensory atypicalities in dyads of children with autism spectrum disorder (ASD) and their parents.
Glod M; Riby DM; Honey E; Rodgers J
Autism Res; 2017 Mar; 10(3):531-538. PubMed ID: 27529166
[TBL] [Abstract][Full Text] [Related]
15. Parent-reported gastro-intestinal symptoms in children with autism spectrum disorders.
Chandler S; Carcani-Rathwell I; Charman T; Pickles A; Loucas T; Meldrum D; Simonoff E; Sullivan P; Baird G
J Autism Dev Disord; 2013 Dec; 43(12):2737-47. PubMed ID: 23371507
[TBL] [Abstract][Full Text] [Related]
16. Relationship between repetitive behaviour and fear across normative development, autism spectrum disorder, and down syndrome.
Uljarević M; Evans DW
Autism Res; 2017 Mar; 10(3):502-507. PubMed ID: 27459229
[TBL] [Abstract][Full Text] [Related]
17. The urinary
Lussu M; Noto A; Masili A; Rinaldi AC; Dessì A; De Angelis M; De Giacomo A; Fanos V; Atzori L; Francavilla R
Autism Res; 2017 Jun; 10(6):1058-1066. PubMed ID: 28296209
[TBL] [Abstract][Full Text] [Related]
18. Reduced endogenous urinary total antioxidant power and its relation of plasma antioxidant activity of superoxide dismutase in individuals with autism spectrum disorder.
Yui K; Tanuma N; Yamada H; Kawasaki Y
Int J Dev Neurosci; 2017 Aug; 60():70-77. PubMed ID: 27554135
[TBL] [Abstract][Full Text] [Related]
19. Skeletal Growth Dysregulation in Australian Male Infants and Toddlers With Autism Spectrum Disorder.
Green CC; Dissanayake C; Loesch DZ; Bui M; Barbaro J
Autism Res; 2018 Jun; 11(6):846-856. PubMed ID: 29624910
[TBL] [Abstract][Full Text] [Related]
20. Differences in age-dependent neural correlates of semantic processing between youths with autism spectrum disorder and typically developing youths.
Chen PJ; Gau SS; Lee SH; Chou TL
Autism Res; 2016 Dec; 9(12):1263-1273. PubMed ID: 26899269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
